SEKISUI Diagnostics Invests £14.4 Million in cGMP Biopharma CDMO Capacity

July 29th, 2020|Tags: , , , |

Burlington, MA, USA – July 29, 2020 – Sekisui announces the decision to invest £14.4 Million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the [...]